The most common causes of chronic cough include gastroesophageal reflux disease (GERD), asthma, and postnasal drip (also ...

Adults with refractory chronic cough who received twice-daily camlipixant had decreases in cough frequency and better scores ...

Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

Bayer says its drug candidate for chronic cough – eliapixant – has hit the mark in a phase 2b trial, putting it in hot pursuit of Merck & Co's gefapixant, which was filed for approval in March.

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...

If your allergies leave you feeling lightheaded or cause chest pain, alert your doctor immediately, Nagarajan said. It could be a sign of a heart problem. Sudden chest pain can be a sign of a heart ...

You could say that allergic disease is a systemic and inflammatory condition,” said Joks, who is both chief of the division and program director of allergy and immunology at ...

That response can lead to chronic inflammation ... Dr. Sairaman Nagarajan, a physician editor at The Merck Manuals and an adjunct faculty member at SUNY Downstate Health Sciences, was lead ...

That response can lead to chronic inflammation ... a physician editor at The Merck Manuals and an adjunct faculty member at SUNY Downstate Health Sciences, was lead author on that study.